My fiancé started treatment for glaucoma 2 months ago. She began using cannabis the day she was diagnosed. The best drug her doctor prescribed for her are just eye drops to reduce eye pressure. The combination of cannabis and the eye drops (she doesn't like the drops due to it making her eyes itchy) seem to be helping her very well. We are continuing to research for treatment. Original poster is not helping cannabis cause by trying to sell online with misinformation...
Thank you for reply, do u know where can I buy the drops "canasol"? Coz my mum won't smoke...
fly down and buy it in jamaica, or find a jamaican (or other caribbean) friend. sorry, i have not been able to find any source for canasol anywhere.
that gmail account above wanted $300 for a 5ml canasol bottle. hah!
you can fly round trip to jamaica for not much more than that.
there might be a way to make your own cannabis oil for use as an eye drop, but i still do not have the recipe for creating your own eye drops.
I've known several Glaucoma patients who benefit from using cannabis, and they eat a small amount of an edible daily.
One of them says that it's not enough to get her high, but her doctor tells her that it keeps her ocular pressure down.
* SOURCE >> - rollitup.org/t/canasol-is-the-best-treatment-for-glaucoma-the-eye-disease.895521/ - for more and to contribute.
Canasol and ocular hypertension
( 02/25/2009 )
hi to all!.. i'm new here.... i'm 28 years hold and my intraocular pression is 24... my oculist tell me to put drop of "timogel"... another one told me to put travatan.. 'cause timogel has too effects "unwanted"!
i've read in internet that canasol reduce intraocular pressione.. anyone use it? does it really works?
i'm in italy.. and here is illegal..
thanks in advance for your help... and sorry for my english!
Login to read more...
You must register because we have content that cannot be viewed unless you agree to our terms and conditions.
* SOURCE >> - www.fiteyes.com/blog/sandro/canasol-and-ocular-hypertension - for more and to contribute.
420 Magazine > Forum >
MEDICAL MARIJUANA >>
Medical Marijuana Doctors
Canasol eye drops needed
I suffer from Glacouma .Can anyone tell me how purchase Canasol eye drops made from Cannabis it ?? Or a Doctor who will prescribe it ?
Thank you , Moriah
FYI, I "HAD" glaucoma for about 20 years. Last June I started using cannabis for glaucoma and pain/inflammation. Last month when I had my eyes checked my pressures were lower than they have ever been and the doc said I could quit using them if I continued whatever I was doing.
I have been using tinctures and eating cookies, along with smoking some now and then.
Sorry I can't help with the drops
* SOURCE >> - www.420magazine.com/forums/medical-marijuana-doctors/275620-canasol-eye-drops-needed.html - for more and to contribute.
gouttes pour soigner un glaucome : le canasol - Phytothérapie ...
bonjour je recherche une officine , un vendeur ou n'importe qui qui puisse me faire obtenir du canasol pour soigner efficacement mon glaucome ( dans les principes actifs du cannabis sativa il y a le thc et un autre principe c'est pas pour se droguer c'est pour se SOIGNER dans l'oeil il y aurait du mal , du reste ....!!!!!!!!!!!!!!!)
je te propose un traitement organo a faire préparer en pharm. ( noter sur papier comme ci-dessous)
corps ciliaire 15ch /
corps ciliaire 18ch / aa qsp 125 ml
corps ciliaire 30ch /
foie 7ch /
40 gouttes au reveil et 15 mn avant le repas du soir
+ exercice occulaire et palming
Bonjour à tous,
Je suis également à la recherche du canasol pour des raisons similaires à celles de General mais pour un stade de la maladie beaucoup plus avancé...J'ai la quasi certitude de l'efficacité du produit et pourtant impossible de trouver un site de vente ou même l'adresse d'une pharmacie à l'autre bout de la terre ...
pourtant le temps presse. Donc si quelqu'un veut bien partager ses recherches avec les miennes, on arrivera peut être à quelque chose.
Moi aussi je recherche ces gouttes "CANASOL", mais ou es t'il en vente ? Dans qu'elle pays ! Je serait prête à me déplacer ...
C'est des gouttes à base de cannabis thérapeutique ou des chercheur ont pris le principe actif du cannabis et qui ferait baissé la tension intraoculaire et qui n'a aucun effet indésirable ou secondaire !
Ces gouttes serait la solution pour les personnes atteinte de glaucome. Il ferait baisser la tension en quelques minutes.
SVP si quelqu'un à des informations sur ce médicament, alors il faut absolument nous renseigner !
- Ou peut t'on nous le procuré ?
MERCI ! ...
Visit - forum.doctissimo.fr/medicaments/phytotherapie/soigner-glaucome-canasol-sujet_144628_1.htm - for more.
other Viable Forums, Bulletin Boards, Chat rooms and other such online resources
will be listed here as we learn about them. Got one? Post It! and let everybody know ...
Jamaican ganja — the race against time >>
Three-day conference at UWI will tell law-makers opportunities slipping away
| (May, 2014)
JAMAICA is already over 40 years behind in decriminalisation of ganja and a three-day conference which kicks off today at the University of the West Indies (UWI) will signal to legislators here that time is not on Jamaica's side.
"We are 40 years late," said Dr Albert Lockhart, a leading opthalmologist who helped pioneer marijuana derived medicines such as Canasol for treating glaucoma, the eye disease and Asmasol for asthma sufferers.
Lockhart, and the late Dr Manley West of the UWI intensified medical research on ganja in 1972 after then Health Minister Dr Kenneth McNeill invited them to address parliamentarians on their work and gave them permission to collect, transport and do research on the weed within the bounds of Jamaica.
The duo produced five drugs, starting with Canasol in 1976. When they saw the potential for greater success, they partnered with the Petroleum Corporation of Jamaica (PCJ) which was being run by the visionary William Saunders to form a commercial enterprise called AMPEC, a combination of the names Albert, Manley and Petroleum Corporation. In 1987, they produced Asmasol.
"We have other drugs that are not yet registered because registration is very expensive," Lockhart said in an interview with the Jamaica Observer, adding that the selling agents in Jamaica for AMPEC is Health Brands Limited.
Lockhart argued that Jamaica should have been much farther ahead in production of ganja for medicinal purposes but that the ball was dropped after the 1972 parliamentary committee breakthrough.
"We have other drugs that are not yet registered because registration is very expensive," Lockhart said in an interview with the Jamaica Observer, adding that the selling agents in Jamaica for AMPEC is Health Brands Limited.
Lockhart argued that Jamaica should have been much farther ahead in production of ganja for medicinal purposes but that the ball was dropped after the 1972 parliamentary committee breakthrough.
He described ganja as "one of the most misunderstood and most maligned drugs", saying: "If you do brain scans on ganja smokers, you will see changes but these changes are temporary, whereas with the use of tobacco and alcohol there is permanent damage to organs."
Lockhart told the Observer that there were ways of benefitting from ganja without smoking. But he noted that the use of a chillum pipe in which water extracts the smoke before it gets to the lungs, was preferable.
SOURCE >> - www.jamaicaobserver.com/news/Jamaican-ganja---the-race-against-time_16714519
Jamaica scientist launches medical marijuana firm
KINGSTON, Jamaica (AP) — A prominent Jamaican scientist and entrepreneur is launching a company that aims to capitalize on medical marijuana, a growing global industry that he asserted Wednesday could be a boon for the island's chronically limping economy.
Henry Lowe, a researcher who specializes in medicinal chemistry and the chairman of an institute that develops therapeutic and cosmetic products from various plants in Jamaica, is calling his new venture Medicanja. It will focus on isolating medicinal compounds in the cannabis plant, known locally as "ganja," and Lowe said the research will not violate any local laws or international conventions.
Lowe said Jamaica could become a powerhouse in the nascent medical marijuana industry, health tourism and the development of innovative pot-derived items. Local scientists already have a history of creating marijuana-derived products, such as "Canasol," which helps relieve pressure in the eyes of glaucoma patients.
"This is a big opportunity for us," Lowe said in a phone interview.
Marijuana is pervasive on the Caribbean island despite being prohibited since 1913. It's long been used as a medicinal herb by Jamaican families and as a spiritual sacrament by Rastafarians. In 2001, a government-appointed commission said pot was "culturally entrenched" and recommended decriminalization, but the effort stalled.
Advocates for pot say it's time for Jamaica to give its moribund economy a boost by embracing cannabis-related ventures. With a growing number of U.S. states changing their marijuana laws, and voters in Washington and Colorado legalizing marijuana, the activists say Jamaica should decriminalize pot and stop worrying that might anger the U.S. The island has long been the Caribbean's biggest pot exporter to the U.S.
Influential politicians are increasingly taking up the idea. Health Minister Fenton Ferguson said last week that he is "fully on board" with medical marijuana, and the justice minister has said the Cabinet should be asked to consider changes to pot laws before the end of the year.
Some church leaders and lawmakers oppose decriminalization of even small amounts of marijuana, arguing the negative effects of the drug outweigh any benefits, especially for young people. But many of them say they have no problem with medical marijuana research.
Visit - www.yahoo.com/news/jamaica-scientist-launches-medical-marijuana-firm-203831144.html?ref=gs - for more.
Canasol The Glaucoma Medical Marijuana Eye Drops | (December, 2013)
After ten years of continuous and diligent research, pharmacologist,
Professor Manley West and ophthalmologist, Dr. Albert Lockhart
developed an eye drop, Canasol, specifically to treat the eye disease,
glaucoma. Glaucoma is estimated to affect 3% of the Jamaican population
and causes pain, visual disturbances and even blindness.
BREAKTHROUGH IN GLAUCOMA THERAPY |
The drug was an important breakthrough, because it is derived from ganja,
Cannabis sativa, and was the first eye medication in the Caribbean to be
developed at UWI, Mona for this disease. Canasol has an important benefit
since it does not induce the negative side effects that are associated with
synthetic glaucoma therapies.
EARLY CLUES FROM FOLK MEDICINE
Professor West became interested in studying the ganja plant because he
had observed that country folk who used an eye wash made up of ganja in
water, always reported to him that it made them see better. The fishermen
who drank ganja ‘tea’ made the same claim and further claimed that their
vision at night was also better.
Dr. Albert Lockhart noted that his Rastafarian patients who used ganja had
a low incidence of glaucoma. More recently, he discovered that the eye
drop, Canasol, improves the integrity of the optic nerve, the nerve which
causes us to see, thus preventing blindness.
SOURCE >> - michiganmedicalmarijuana.org/topic/45288-canasol-the-glaucoma-medical-marijuana-eye-drops/ - for more.
Give me credit for early work on Canasol --
Henry Lowe, Guest Columnist
(September, 2013) NOTE: Reference is made to Dr Albert Lockhart's letter to the editor titled 'Clarifying school of marijuana', which was published in The Gleaner on September 4, 2013.
While I have no problem or issues with a gentleman like Dr Lockhart (who I have been associated with for decades) expressing his views, I was very surprised by his absolute negative statement: "I must point out that at no time was Dr Henry Lowe involved in the development of Canasol."
Factual history speaks for itself and, therefore, in my view, there is no need on my part for further dialogue on this subject beyond these points noted now or in the future:
The work on Canasol can be said to have started in the science laboratories at CAST (now the University of Technology) soon after I returned from the University of Sydney School of Pharmacy in 1970, with an MSc in pharmaceutical/medicinal chemistry.
The story of how the late Dr Manley West and I started this work is of great human interest and related to his observations on the Portland fishermen and how they could see the 'fish run' to get large catches after they smoke ganja.
Dr West had recently returned to Jamaica as a lecturer in pharmacology at the University of the West Indies after completing his PhD (in pharmacology) at the University of London. As we all know, he dedicated his life to work on the pharmacology of Jamaican medicinal plants, and we are all proud of his excellent legacy.
We started discussing ganja research for medicinal purposes. Dr West was appointed by me, in my then capacity of head of the Science Department at CAST, to teach pharmacology on a part-time basis to the pharmacy students. During that time, we always found time for dialogue and, quite frequently, found time to meet socially and to have discussions on the subject of Jamaican medicinal plants and other matters of mutual interest.
Having decided to do the research and development on ganja, the records will show that we got permission from the then minister of national security, Keble Munn, to research ganja for medicinal purposes. This activity was actively supported by the then parliamentary secretary in the Ministry of Health, Dr Winston Davidson.
We were then later supported by Hawthorn Watson (currently executive director of Scientific Research Council), who did a thesis for his master's degree, on ganja. Mr Watson, who was then a lecturer in science at CAST, gave invaluable help, particularly in the isolation of the tetrahydro-cannabinol (THC) from ganja, which was the first chemical entity to be pharmacologically tested for its bioactivity against glaucoma.
Later on, other non-THC components of ganja were isolated and tested by the team, which eventually led to the formulation and production of Canasol, with Dr Lockhart's major contributions. While it is a fact that I did not participate in the actual commercial production of Canasol, I was involved in all of the fundamental scientific research and development activities, without which the commercial Canasol could not be produced. The main reason for my non-continuation of this work with the team was because I left the island to do my PhD and was away for approximately two years, after which I decided to join the Government as director of energy.
The rest is history and the evidence exists to show that not only was I involved in the cannabis (ganja) research, but we authored at least one joint publication on this subject titled 'The Potential Use of Cannabis Sativa in Ophthalmology', West Indian Med Journal 1977 Jun;26(2):66-70. This article directly relates to the Canasol research and was subsequently quoted in several scientific publications.
I go on further to say that when the Cannabis Research Institute was formed, with me being the first chairman in 2002, Dr West was invited to serve as a member of the board of directors. Dr West gave his full support to the venture and he told me, "It was a pity that I was never publicly referenced in any of the early recognition on glaucoma work on cannabis, particularly on the aspects of medicinal chemistry."
It was only since then that I started making reference to my involvement with the Canasol work, which few persons know about.
I trust this will clear the air and we can move on with our scientific research and development to serve the world at large, but, more specifically, the people of Jamaica.
* SOURCE >> - jamaica-gleaner.com/gleaner/20130911/cleisure/cleisure2.html - for more.
GraceKennedy Announces the Sale of MediGrace
(July, 2013) GraceKennedy Limited announces the sale of Medi-Grace Limited to Smith Russell & Company
Limited, a company which is engaged in the distribution of pharmaceutical and consumer
products. It is expected that the sale will be completed by August 31, 2006.
Medi-Grace Ltd. is involved in the distribution of pharmaceutical and consumer products, and
represents such well known companies as Eli Lilly, Merck Sharp & Dohme, and Pfizer
It is expected that under the new ownership, Medi-Grace will continue to
operate as an independent company focusing on the pharmaceutical industry.
Based on the terms of the agreement, certain consumer products with the
brand names, Dial, Soft Sheen and Energizer now carried by Medi-Grace will be transferred to
World Brands Ltd.
SOURCE >> - www.ecseonline.com/PDF/_GK_Grace_Sale%20of%20Medigrace%2013%20July%2006.pdf
Manley West, science and technology
(April 29, 2012)
Professor the Honourable Manley West, one of the famous pair of ganja men of science, passed on last Tuesday.
West, a pharmacologist, and Dr Albert Lockhart, an ophthalmologist, developed from the ganja plant the drug Canasol for the treatment of glaucoma, as well as Asthmasol, for the treatment of asthma. Long before these developments, folklore had it that ganja improved the night vision of fishermen and relieved asthma.
For their efforts, and a sort of backhanded compliment to the power of the weed on which they worked, both scientists were awarded the nation's third-highest honour, the Order of Merit (OM). The OM is conferred upon citizens of Jamaica who have achieved eminent international distinction in his or her field of endeavour. No more than two can be awarded each year, and there can be no more than 15 living members of the order.
SOURCE >> - jamaica-gleaner.com/gleaner/20120429/focus/focus4.html
Wonder drugs from ganja - Britain approves cannabis-based medicine
In a recent article in The Economist, it was disclosed that victims of multiple sclerosis (MS) since June 21 this year can legally purchase a marijuana-based medicine known as Sativex in Britain to alleviate the excruciating pain and spasms associated with their condition.
Jamaica, which has an enduring cultural and law-enforcement association with the herb, had set the pace globally in terms of research and development of legal drugs from ganja since the 1970s through the groundbreaking efforts of Professor Manley West and Dr Albert Lockhart at the University of the West Indies (UWI).
Back then, Professor West and Dr Lockhart isolated a compound in cannabis which they discovered could be used in the treatment of glaucoma, a broad term which encompasses disorders of the eye in which pressure within the eye is elevated, resulting in damage to the organ causing pain, visual disturbances, and even blindness.
The upshot of their collaboration was the development of canasol, which contains an alpha agonist, which helps to relieve the pressure in the eye without the side effects of other therapies.
Cantimol is another drug that was introduced to the health market courtesy of Professor West and Dr Lockhart. It is a combination drug, the first of its kind, consisting of canasol and timolol maleate (a beta blocker), both of which are necessary for glaucoma therapy. Prior to the efforts of West and Lockhart, canasol and timolol maleate were delivered separately.
According to health sources, an estimated three per cent of Jamaica's population suffers from glaucoma, while in the United States, glaucoma is the leading cause of preventable blindness, affecting more than two million Americans, which points to the vast market potential of such drugs.
Ja still fighting ganja
Meanwhile, back in Jamaica, the fight to eradicate ganja continues to consume significant resources of the security forces and the wider legal system, with hundreds of prosecutions annually for trading in and using the herb.
Professor West's work has not gone unnoticed, however, and in 1987 he received the nation's third highest national award, the Order of Merit, along with Dr Lockhart, for their work on developing canasol.
* SOURCE >> - jamaica-gleaner.com/gleaner/20100822/news/news2.html - for more.
Jamaican Doctors Develop first Glaucoma medication in the Caribbean
| (August 16, 2009) Professor Manley West - Contributed Glaucoma is estimated to affect three per cent of the Jamaican population and causes pain, visual disturbances and even blindness. Today, many persons affected by the disease are receiving relief from a drug developed by medical personnel associated with The University of the West Indies, (UWI) Mona campus. The eye drop, Canasol, was developed after 10 years of continuous and diligent research by pharmacologist, Professor Manley West, and ophthalmologist, Dr Albert Lockhart, specifically to treat glaucoma.
Professor West is an emeritus professor of pharmacology in the Faculty of Medical Sciences at UWI, Mona. Both he and Dr Lockhart received the Order of Merit from the Government of Jamaica and the Gold Musgrave Medal from the Institute of Jamaica for the development of Canasol.
The drug was an important breakthrough because it is derived from ganja, and was the first eye medication in the Caribbean to be developed at UWI, Mona for this disease. Canasol has an important benefit since it does not induce the negative side effects that are associated with synthetic glaucoma therapies.
Professor West became interested in studying the ganja plant because he had observed that country folk who used an eye wash made of ganja in water always reported to him that it made them see better. The fishermen who drank ganja tea made the same claim and further claimed that their vision at night was also better.
Dr Lockhart noted that his Rastafarian patients who used ganja had a low incidence of glaucoma. More recently, he discovered that the eye drop, Canasol, improves the integrity of the optic nerve, the nerve which causes us to see, thus preventing blindness..
In the early 1990s, Professor West also developed the drug Asmasol, to treat asthma, colds and the flu. The doctors who are now using this drug report that they prescribe it for children as well as adults, and that it is effective during both the early and the late phases of the condition. Asmasol is a derivative of ganja and is available in pharmacies throughout the Caribbean.
SOURCE >> - www.abibitumikasa.com/forums/showthread.php/40807-jamaican-doctors-develop-first-glaucoma-medication-in-the-carribean - for more.
Canasol and Cantimol, that effectively treat glaucoma.
(May, 2005) CONTROVERSY OR not, local scientists, Dr. Henry Lowe and Professor Errol Morrison note in their book the History of the use of Marijuana that ganja is liberally used by the folk in soups, cakes and cookies. The leaves are brewed and the tea taken as tonic or crushed and applied as an ointment to cure various conditions. In common folk preparations, the green leaves or buds are soaked in white rum (sometimes tempered with fruit juice) and used for the relief of stomach ache, toothache and symptoms of asthma.
Clinical evidence supporting ganja’s effectiveness in treating symptoms, such as pain, nausea, vomiting and appetite loss has been compiled by the United States Institute of Medicine/National Academy of Sciences (1999), which also notes that ganja’s primary active ingredient, THC (or delta-9-tetrahydrocannabinoids), has been approved by the U.S. Food and Drug Administration (FDA) under the name dronabinol and marketed as Marinol.
On the issue of eye disease, glaucoma, the IOM report states that "the potential harmful effects of chronic marijuana smoking outweigh its modest benefits in treating glaucoma" and that more research is required to isolate, its therapeutic effect against high intraocular pressure (IOP).
Most Jamaicans would already be aware that two highly-acclaimed local scientists, Drs. Manley West and Albert Lockhart, have already isolated ganja’s therapeutic compound and have
developed two drugs, canasol and cantimol, that effectively treat glaucoma.
Cantimol is a combination of canasol, an alpha agonist and timolol maleate, a beta blocker.
* Visit - www.chanvre-info.ch/info/en/Canasol-and-Cantimol-that.html - for more.
Hemp Info > Hemp and Medicine > File Glaucoma >>
Jamaica: Ganja-based eyedrops a hot sell
(August, 2003) CANASOL, THE locally produced drug used for the treatment of the eye disease, glaucoma, is now in high demand both on the local and international market.
The product, a derivative from cannabis (ganja), was at first received with much scepticism and doubt, but according to ophthalmologist Dr. Albert Lockhart, one of the developers of the product, patients from Florida, California, Pennsylvania, Washington D.C., New York and Massachusetts in the United States are now using it.
"We have to try to educate people and let them know that Canasol does not contain any psychoactive agents" from ganja, he said.
The product is currently being distributed in Jamaica by Medi-Grace Limited and, according to Dr. Lockhart, they have also exported to England, some Caribbean islands, and it is sold directly based on doctor’s prescriptions from the United States.
According to sources at Medi -Grace Limited, an average of 400 units are sold per month, and pharmacists across Jamaica have agreed that "the product sells like hot bread."
"There is a great demand for the product," Mrs. C. Law a pharmacist at Dolphin’s Pharmacy in Kingston said, adding that persons even send from abroad to get it.
The Canasol eyedrop, a derivative from cannabis (ganja) that is used in the treatment of glaucoma.
According to her, they had a customer from Canada who usually orders a six-month supply and have it delivered by airmail. She says the pharmacy usually orders 1,500 bottles of Canasol at a time, as supplies normally sells fast.
According to Mrs. Law, compared to other eye-drop drugs, Canasol is relatively cheap selling for as little as $285 per bottle, while other eyedrops (same size bottle) cost $1,897.
Now reaping the fruits of success after years of research and experimentation, Dr. Lockhart is content with the work that he and his research team has been doing. "There is a lot of personal and professional satisfaction. The financial part is secondary," he says.
Research on the product was started in 1973, but it was not until late 1980s, that the research team including Dr. Manley West, was able to get the product in a marketable state for it to be commercialised.
While explaining some of the rigours of producing Canasol, Dr. Lockhart pointed out that the environment in which the raw material (ganja) was produced, had to be very controlled. "We are controlled supply-wise, and we have to be able to account for whatever (ganja) we get."
He described it as a very efficient system of production, as small quantities of ganja are able to produce sufficient amounts of Canasol.
"Fifty pounds of ganja will give us all we need (at the moment) for a year," he said, as roughly 30,000 vials of Canasol are produced each year. Research, however, did not cease after the development of Canasol, as further studies and experimentation led the doctor and his team to more discoveries in the medical uses of ganja.
Recently, two new ganja-based products have been developed Asmasol (a drug used to treat asthma, coughs and colds), and Cantimol (which also contains Canasol), and is a more potent drug used in the treatment of glaucoma. Cantimol, however, has not yet been approved by the Ministry of Health, Dr. Lockhart said.
A third product has been developed for the treatment of motion sickness and comes in the form of a nose drop. It is still being tested however.
Dr. Lockhart said this drug would eliminate the side-effects like drowsiness and blurred vision that come with other motion sickness drugs.
* SOURCE >> - www.chanvre-info.ch/info/en/Jamaica-Ganja-based-eyedrops-a-hot.html - for more.
Ganja medicine in Jamaica
(January, 2000 ) -
Your eyes are infused with a fluid called aqueous humor that keeps them round, nourished and juicy. The pressure inside your eyes is called intraocular pressure, and is partially the result of a balance between the production, inflow and outflow of aqueous humor. If this balance is upset and your intraocular pressure rises to abnormally high levels, you are a victim of glaucoma.
As in the case of Robert Randall, president of Alliance for Cannabis Therapeutics and the first US glaucoma sufferer to win formal government approval for using cannabis as a glaucoma buster, raised eye pressure leads to destruction of the retina and other important parts of the eye. You gradually lose vision, and eventually may become totally blind.
EYE AND EYE
Dr Manley West is an emeritus professor and administrator who runs a pharmacology lab at the University of the West Indies (UWI) campus in Kingston. He has worked with ophthalmologist Dr Albert Lockhart on pioneering research that turns raw ganja into specialty medicines for glaucoma and other disorders.
West and Lockhart were trained at prestigious academies in England, Scotland and the United States. West has been the head of UWI’s pharmacology department, and has nearly 40 years of experience in medicine and health. Lockhart has 36 years experience as a researcher and ophthalmologist. The lauded duo has received two of Jamaica’s highest medical honors: the Order of Merit for Medicine and the Musgrave Gold Medal. Why were they honored? Because they created Canasol, a ganja-based medicine that helps decrease intraocular pressure with none of the side effects caused by other treatments.
West explained that he and Lockhart began studying cannabis-glaucoma pharmacology in the early 1970’s. Scientists had long known that cannabis lowered intraocular pressure, but instead of utilizing whole smoked cannabis, American researchers spent millions of dollars on a poorly-designed topical THC eyedrop treatment that had caused eye irritation and failed to decrease intraocular pressure.
While Randall smoked ganja, found it a miracle medicine, and fought the US government’s attempts to prevent him from using it, West and Lockhart were doing innovative experiments to determine which ganja constituents were responsible for marijuana’s anti-glaucoma effects. The Jamaican government granted them an official new drug certification for Canasol in February 1983.
“It was a breakthrough,” West explained. “I had long been interested in finding therapeutic compounds derived from natural origins. Glaucoma hits blacks sooner in life, progresses faster, and more often results in blindness. About 100,000 of our 3 million island population has it. Other glaucoma medications produced side effects, and the only other treatment was surgery, which is also risky.
We wanted a safer, more affordable medicine for Jamaicans. Canasol appears to be the answer. It works within minutes to lower pressure, even in patients who have rare forms of glaucoma or have not responded well to other treatments.”
Dr Lockhart, who resides in Jamaica and in Dallas, Texas, said he first became interested in ganja’s possible medical benefits in 1971.
“The fishermen told us that ganja improved their vision at night,” Lockhart explained. “Some people had dismissed that as only an imagined improvement, but we looked into it, and found that ganja was affecting blood flow to the retina.”
Although early research and cultural lore indicated promising medical uses for ganja, West and Lockhart found their development of cannabis therapeutics complicated by drug war politics, as well as the daunting realities of pharmaceutical research, development and approval processes.
“Jamaica has a traditional ganja culture,” said Lockhart, who augmented his medical training by earning an MBA in 1986. “That may have made it easier for us to get approval, beginning in 1972, for strictly-regulated research protocols and collection of ganja for medical purposes. We also received government business assistance in the 1980’s that helped form a corporation to assist in manufacture and marketing.”
Citing drug war politics and fear of persecution, West and Lockhart were extremely reluctant to discuss details of their Jamaican ganja research, but reports they’ve published regarding animal and human test procedures used to measure the efficacy of ganja pharmaceuticals indicates they had access to high-quality marijuana, and that constituents from the miracle plant were isolated via physical, chemical, temperature, and filtration manipulations, then given to people and animals with glaucoma and other ailments.
Lockhart indicated that Jamaican government agencies and officials, including the Ministry of Security and Justice, the Ministry of Environmental Control and Health, the Police Commissioner, and local police agencies were instrumental in ensuring a safe, legal supply of raw cannabis. Ironically, their source is plants seized from other ganja growers.
“We have Jamaica pretty well mapped out,” Lockhart explained. “The police know that if they seize what looks to be high grade ganja, they are to call us so we can determine if this is a possible research material source.”
In an article published in the West Indies Medical Journal in 1978, West wrote: “Sun-dried whole plant (cannabis sativa) was obtained from the Police Department. The material was carefully examined for extraneous matter. A macerate was made which contained 5% w/v of whole cannabis. The solution was filtered using Whatman’s No. 1 filter paper and the solution rapidly sterilized using a sintered glass filter (5 on 3) with a porosity of 1 to 1.5 microns. The sterilized solution was distributed aseptically into eye drop containers and stored in a cool dark place above freezing point.”
Neither West nor Lockhart would elaborate on the exact procedures used to transform the above-mentioned solution into a prescription medicine, although Lockhart did say that a stable “powder” had been made in sufficient quantity to supply the experimenters with all the “principle” they needed to conduct numerous experiments and to make stable pharmaceutical preparations. Canasol has been stored at varying temperatures for eight years, West noted, and had no significant loss of potency.
During the 1980’s and 90’s, West said, thousands of vials of Canasol have been tested and used as a topical eye medicine in Jamaica, Europe, the Caribbean, the South Pacific and other areas.
“It has no reported side-effects,” West emphatically stated, “which makes it safer than the standard chemical glaucoma medications. It acts very quickly, both as a preventive and in situations of acute onset, to lower intraocular pressure. Patients report excellent results and ease of use, and doctors are quite happy to have Canasol in their therapeutic arsenal. It is part of the curriculum in medical schools, during courses that discuss drugs affecting the eye.”
With Canasol increasingly accepted by doctors and patients worldwide, the Jamaican researchers turned their attention to other medical uses of ganja constituents. In 1990, they released Asmasol, a cannabis derivative that helps relieve asthma attacks.
“Asmasol is useful during both the acute phase of an asthma attack, and as a preventive during the impending phase,” West explained, adding that he and Lockhart have also created Canavert, a ganja-based treatment for motion sickness, and are working on Cantimol, another glaucoma medication slated for imminent release.
More research is planned, as the imaginative team looks into ganja’s effects on nausea, arthritis, pain and migraine headaches.
“This plant has hundreds of potentially helpful constituents,” West explains. “It is useful for many conditions, and is a storehouse of amazing proportions.”
BLINDED IN BABYLON
The US Institute of Medicine report issued in early 1999 claimed that smoking cannabis causes health and psychological problems, and recommended that “safer” cannabis delivery systems be developed.
It would appear that the medicines developed by Lockhart and West met those criteria years ago.
“Everybody wants to find out how we got rid of the psychoactive components and isolated the active principles,” Lockhart explained. “They even went to our manufacturer and government officials, trying to get information. They are confused by a mindset that holds that THC is the only active principle.
But there is more than one variety of this plant, and many different combinations. We have tested these principles on every part of the body, including injecting into the brain. We have reams and reams of data on how this works. We have had no reports that these therapies have a systemic affect on patients in a way that would be described as psychoactive.”
But reams of data didn’t impress the US Food and Drug Administration (FDA), which means that Canasol and other ganja pharmaceuticals developed by the Jamaican researchers cannot be legally obtained as prescription drugs in the US. Lockhart admits to being frustrated about the FDA blockade, but says the agency estimated that it would cost the Jamaican team tens of millions of dollars to pay for research needed to obtain US approval of Canasol.
“The FDA doesn’t recognize foreign experiments. It doesn’t consider our dogs, rats, cats and people as valid test subjects, because they are not American test subjects,” Lockhart quipped. “They seemed interested in having us hand it over to a big corporation. It was actually quite funny, when some companies wanted to pay us a pittance for our work, to give up all our rights to it. An insult really. And the FDA policy was to deny the medical value of any natural derivative of cannabis, but they allowed the synthetic derivative, Marinol, and that derivative was of very limited application. US medical journals also discriminate against research done outside the United States.
We are two little guys from a Third World country. We do this for knowledge and to help people. We test our discoveries and find those that work safely, then we publish the results. But we do not have enough money to challenge the US authorities.”
Lockhart and West reported that clinical trials and anecdotal information indicate that Canasol is safe and effective. Lockhart said that the only problems they’d encountered occurred when a few vials of Canasol produced mild, temporary eye discomfort. The problem was corrected by creating a different type of vial.
SOURCE >> - www.cannabisculture.com/content/2000/01/16/59 - for more.
RxMarijuana.com | Marijuana: The Forbidden Medicine.
(ORG, inf, Book) Featured Medical Marijuana Patient Accounts * to share website visitors' medical marijuana histories to provide insight into uses for this medicine which are not widely known. … If you wish to send us a personal account of your medical marijuana experiences, ... Cannabis and Canasol by Michael McKenna ... visit: www.rxmarihuana.com/shared.htm
(web-ring / link-list) * Your starting point for the best medical info. Free Medical Cannabis info Find what you're looking for! Visit: www.medical-101.com/s/medical_cannabis
Talk with your doctor about the best Treatment plan for you. A review of Treatment options:
Updated NORML Report Highlights Marijuana's Role In Moderating Disease Progression; 'Emerging Clinical Applications' Booklet Reviews Nearly 200 Studies On The Therapeutic Use Of Cannabis
Clinical and preclinical research on the therapeutic use of cannabis indicates that cannabinoids may curb the progression of various life-threatening diseases – including multiple sclerosis, Alzheimer's disease, and brain cancer, according to an updated report published by the NORML Foundation.
NORML Deputy Director Paul Armentano, who authored the report, said: "The conditions profiled in this report were chosen because patients frequently ask me about the use of cannabis to treat these disorders. Ideally, with this report in their hands, patients can now begin talking openly with their physicians about whether cannabis therapy is appropriate for them."
Visit - norml.org/component/zoo/category/recent-research-on-medical-marijuana - for more.
Medical Use of Cannabis (marijuana) | Here to Help
> On this page:
How does cannabis work as medicine?
What conditions or symptoms is cannabis used to treat?
How do people use cannabis for medical purposes?
What is pharmaceutical cannabis, and how does it compare to herbal cannabis?
What are the side effects and risks of using cannabis to treat symptoms or medical conditions?
Is using cannabis for medicinal purposes legal?
What are compassion clubs?
What are some barriers to using cannabis for medicinal purposes?
What to do if you or someone you know needs more information about medical cannabis
Visit - heretohelp.bc.ca/factsheet/medical-use-of-cannabis - for more.
HowStuffWorks "How Medical Marijuana Works"
| So how, exactly, does medical marijuana work to treat these conditions? Why, if this medicine is so effective for some people, does it remain controversial and, in many places, illegal? In this article, we'll take a look at the medical, legal, and practical issues surrounding medical marijuana in the United States. We'll examine why some people, like Burton Aldrich,
depend on it to live normally. We'll also examine some of the intriguing intersections between pharmaceutical companies, the government and the medical marijuana industry. Visit - science.howstuffworks.com/medical-marijuana.htm - for more.
Medical Marijuana Benefits, Helps These Conditions
| You might be surprised to find that it wasn’t just ancient peoples who used the drug; marijuana remained in the United States pharmacopoeia until 1941. Up until that time, cannabis was freely available in shops and, in the UK, Queen Victoria, that most conservative of royals, used cannabis to alleviate her menstrual cramps. ... are predominantly using cannabis to treat symptoms of ...
We believe Medical Marijuana will help these conditions:
Please let us know your experiences in using medical marijuana to treat various conditions.
Visit - www.medicalmarijuanablog.com/benefits/conditions-helped.html - for more.
Medical marijuana (cannabis) - common uses
| Common Medical Uses for Cannabis (Marijuana) ... Medical Marijuana Dispensaries - Directory of Medical Marijuana ... Cannabidiol improves symptoms of generalized social anxiety disorder in…
... Physicians, Cannabis Cooperatives and Dispensaries
Medical Marijuana Dispensaries - Directory of Medical Marijuana Dispensaries
Cannabinoid Profiles of Cannabis Strains
Cannabis Laboratories: The Testing Landscape in America
An Overview of the Endogenous Cannabinoid System
Visit - www.letfreedomgrow.com/cmu/index.htm - for more.
Complete List of Conditions Treatable With Marijuana
| Check out the articles below to learn about how medical marijuana can be useful in treating specific medical conditions. We'll help you find the best ways to ingest medical marijuana to
treat your condition, what strains will be most beneficial and we'll even help you connect with other folks with the same condition.
Visit - medicalmarijuana.com/treatments-with-medical-marijuana-cannabis - for more.
dical Conditions Treated by Cannabis, INFO from ORG" >
What symptoms do patients treat with ... , Salt Lake City Medical Marijuana ... representative for the American Alliance for Medical Cannabis ...
One question the 2011 Medical Marijuana Survey (sponsored by Legalize Utah) queried which
received some of the most detailed responses was” “Do you use Medical Marijuana to treat any physical or psychological conditions and if so, which conditions”.
Visit - www.examiner.com/article/what-symptoms-do-patients-treat-with-medicinal-cannabis - for more.
Marijuana: 1276 user reviews - DailyStrength | (INF)
Medically, cannabis is most often used as an appetite stimulant and pain reliever for certain ... Canasol, Narcolepsy, Obsessive Compulsive Diso. ... I use medical marijuana o...
(also known as Cannabis)
Medically, cannabis is most often used as an appetite stimulant and pain reliever for certain illnesses such as cancer, AIDS and other diseases. It is used to relieve glaucoma and certain neurological illnesses such as epilepsy, migraine and bipolar disorder. It has also been found to relieve nausea for chemotherapy pa... more at Wikipedia
Treatment Success Rates ...
Top 5 Communities;
Condition, Members, Success -
Chronic Pain, 684, 86%;
Depression, 55 96%;
Bipolar Disorder, 44, 95%;
Anxiety, 32 94%;
Fibromyalgia, 26, 100%;
Overall, 90% (1106 Members) - find Marijuana helpful
Visit - http://www.dailystrength.org/treatments/Marijuana - for more.
RxMarihuana.com: Index of Medical Conditions | (INF)
Marijuana: The Forbidden Medicine. Index of Medical Conditions Addressed We will soon ... MUSCLE SPASM
MYOFASCIAL PAIN SYNDROME
... and more.
Visit - http://rxmarijuana.com/medical_conditions.htm - for more.
Tetrahydrocannabinol - Wikipedia, the free encyclopedia | (INF)
Tetrahydrocannabinol (tet-ra-hy-dro-ka-nab-i-nol; THC), also known as delta-9-tetrahydrocannabinol (Delta9-THC), Delta1-THC (using an older chemical nomenclature), or dronabinol, is the main psychoactive substance found in the cannabis plant.
... Two studies indicate that THC also has an anticholinesterase action which may implicate it as a potential treatment for Alzheimer's and Canasol.
Visit - http://en.wikipedia.org/wiki/Tetrahydrocannabinol - for more.
Expectations (prognosis) for Canasol treatment.
Complications of Canasol treatment.
Marijuana Toxicity - Mar Vista Animal Medical Center | (BIZ)
Jan 26, 2011 ... Canasol ? Cat Neonatal Isoerythrolysis ... done with humans can be done in dogs to make the diagnosis of marijuana intoxication. ...
Marijuana, known by many names, needs very little introduction; we all know it is a popular recreational drug smoked illegally by millions of people worldwide. Its psychoactive ingredient is delta 9-tetrahydrocannabinol, more commonly called “THC.” Regular marijuana is typically 1-8% THC while hashish, made from the flowering tops of the plant and their resins, can contain up to 10% THC. Other properties of
THC give it controversial medicinal properties: appetite stimulation and nausea control.
Visit - http://www.marvistavet.com/html/body_marijuana_toxicity.html -- for more.
(back to top)